Bristol-Myers Squibb Co. (BMY)

Drugs will enhance our quality of life and they are just now getting started. BMY has a good portfolio and management is focused on enhancing revenues for future growth. Great dividend also. What's not to like?

Strong dividend, strong earnings. This one adds some safety to my real life aggressive portfolio

Fat yield.

BMY is a solid company with a great dividend. People will be looking for such a stable company to balance their portfolios. I don't think Obama's health care plan will hurt it either.

Lilly is about to lose its protection (patents expiring). There will be rationalization in the industry as players take advantage of new generic-drug alternatives. BMY has saved the cash needed to make some good acquisitions, which will accelerate its performance.

good time to buy - good dividend @ 5.5% - real potential for takeover in near furure-eh

safe high yield

positive independent ratings. best drug manufacturer. S&P 5 stars. 5.5% div. historically low PE of 13 x's trailing EPS.

Abilify for adjunctive treatment of depression has been a huge success and patients are reporting results within 1-2 weeks which is unprecedented for an antidepressant (unless it's placebo effect). Analysts are aware of the potential here, but I think the next set of earnings will beat.

Momentum / defensive pick

P/E is not overly high. There's a good dividend and they have enough cash on hand to completely cover their LT debt.

Leading Pharma

Quality Med Related company, Bargain price, Great Dividend history. I like my chances.

Passws the Geraldine Weiss criteria as of Sep 6, 2009

High dividend yield, Underpriced. Low risk and steady growth

Drug company that produces everyday items. Enough said.

Another addition to my pharma collection

Best drugs I ever had

Bristol Myers has just purchased a company, one that is costly not creating cash flow yet. Set back = Time Medex does have diamonds awaiting them with BMY's good management.